The main objectives of the present article were to systematize the modern views of the causes and risk factors of allergic rhinitis, to clarify the manner of its development, to define the leading etiological mechanism underling the pathogenesis of this condition, to consider the methods used for the diagnostics and the treatment of this disease, and to sum up the clinical experience with the use of Levocetirizine (Allerwey) for the management of allergic rhinitis. Special attention is given to the achievement and the maintenance of control of the persistent or intermittent forms of allergic rhinitis and to approaches to its treatment based on the medications registered in the Russian Federation.
Цель работы - обобщить клинический опыт применения левоцетиризина (аллервэй) в достижении и поддержании контроля над симптомами персистирующей и интермиттирующей форм аллергического ринита. Представить терапию с учетом лекарственных средств, зарегистрированных в Российской федерации.
Keywords: Allerway; H1- histamine blockers of the second generation; allergic diseases; atopy; levocetirizine; nasal obstruction; rhinorrhea; sensitization.